Exact Sciences

Meeting patients where they are is key to improving colorectal cancer screening rates. Data presented at #ACG2024 suggests that providing Spanish-language materials is just one way to help close the screening gap in the Hispanic community. Read more: https://bit.ly/3YodNDQ

In health care, patients and providers want only the best tools in their toolbox. To help identify effective solutions, a model known as the efficient frontier is used to identify and recommend optimal care solutions. Learn how the efficient frontier is used to evaluate colorectal cancer screening methods: https://bit.ly/3C29c2E

Our team is in Philadelphia attending #ACG2024. We’re looking forward to sharing data that demonstrates the effectiveness of Cologuard Plus™ as a noninvasive colorectal cancer screening strategy. Read more: https://bit.ly/4hnxbJJ American College of Gastroenterology

When Katherine was diagnosed with breast cancer in 2003, she wanted to avoid chemotherapy, if possible. She came across a test that could help her determine whether chemotherapy would benefit her, but there was one problem: it wasn’t yet available. She called every day, and when the Oncotype DX Breast Recurrence Score® test was finally approved in January 2004, she was the first person to use it. Hear her story: https://bit.ly/4f8LJuV Katie Couric Media #BreastCancerAwarenessMonth #20YearsofOncotypeDX

Many patients may benefit from hereditary cancer testing, no matter where they are in their breast cancer experience. Tests like the Riskguard™ hereditary cancer test can help inform early detection and risk-reducing strategies, as well as potential targeted therapy options. Learn more: https://bit.ly/44JHKkD #BreastCancerAwarenessMonth

Breast cancer care has come a long way, and innovative genomic tests like the Oncotype DX Breast Recurrence Score® test have transformed outcomes for patients. Keep watching and hear more from our very own Rick Baehner, MD: https://bit.ly/4f8LJuV Katie Couric Media Katie Couric #20YearsofOncotypeDX #BreastCancerAwarenessMonth

At #HLTHUSA, Tomasz (Tom) Beer joins a panel to explore trends in cancer's prevalence and share how multi-cancer early detection (MCED) tests could help address them. Looking forward to the discussion with Pfizer’s Karin Tollefson, City of Hope's Harlan Levine, Massachusetts General Hospital's Aparna Parikh, and AlleyCorp's Brenton Fargnoli. #HTLH2024 https://lnkd.in/eg9vDN_X

Our global teams in Switzerland and the UK have been busy this #BreastCancerAwarenessMonth raising awareness for the importance of early breast cancer detection. Through regular breast self-exams, women can take proactive steps to get ahead of their health. Learn more: https://bit.ly/3BNajDn Breast Cancer Now, Future Dreams Breast Cancer Charity

Amy’s breast cancer diagnosis was a surprising and scary experience, but she found comfort in hearing the stories of other women who had fought the disease and survived. Now, she shares her own story to support those who are facing a diagnosis. Read more: https://bit.ly/48giGn2 #BreastCancerAwarenessMonth

This #HispanicHeritageMonth, we’re proud to celebrate our teammates and the warm, vibrant culture that they bring to Exact Sciences every day. Find out how their Hispanic heritage empowers their success, both personally and professionally. #WeAreExact